Skip to main content
Erschienen in: Diabetologia 7/2004

01.07.2004 | Article

Simple non-invasive assessment of advanced glycation endproduct accumulation

verfasst von: R. Meerwaldt, R. Graaff, P. H. N. Oomen, T. P. Links, J. J. Jager, N. L. Alderson, S. R. Thorpe, J. W. Baynes, R. O. B. Gans, A. J. Smit

Erschienen in: Diabetologia | Ausgabe 7/2004

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

The accumulation of AGE is thought to play a role in the pathogenesis of chronic complications of diabetes mellitus and renal failure. All current measurements of AGE accumulation require invasive sampling. We exploited the fact that several AGE exhibit autofluorescence to develop a non-invasive tool for measuring skin AGE accumulation, the Autofluorescence Reader (AFR). We validated its use by comparing the values obtained using the AFR with the AGE content measured in extracts from skin biopsies of diabetic and control subjects.

Methods

Using the AFR with an excitation light source of 300–420 nm, fluorescence of the skin was measured at the arm and lower leg in 46 patients with diabetes (Type 1 and 2) and in 46 age- and sex-matched control subjects, the majority of whom were Caucasian. Autofluorescence was defined as the average fluorescence per nm over the entire emission spectrum (420–600 nm) as ratio of the average fluorescence per nm over the 300–420-nm range. Skin biopsies were obtained from the same site of the arm, and analysed for collagen-linked fluorescence (CLF) and specific AGE: pentosidine, N ε -(carboxymethyl)lysine (CML) and N ε -(carboxyethyl)lysine (CEL).

Results

Autofluorescence correlated with CLF, pentosidine, CML, and CEL (r=0.47–0.62, p≤0.002). In 32 of 46 diabetic patients (70%), autofluorescence values were above the 95% CI of the mean value in control subjects, and correlated with age, diabetes duration, mean HbA1c of the previous year and creatinine levels.

Conclusions/interpretation

The AFR offers a simple alternative to invasive measurement of AGE accumulation and, to date, has been validated in non-pigmented skin. The AFR may prove to be a useful clinical tool for rapid risk assessment of AGE-related long-term complications in diabetes mellitus and in other conditions associated with AGE accumulation.
Literatur
1.
Zurück zum Zitat Schleicher E, Wagner E, Nerlich AG (1997) Increased accumulation of the glycoxidation product N ε -(carboxymethyl)lysine in human tissues in diabetes and aging. J Clin Invest 99:457–468CrossRefPubMedPubMedCentral Schleicher E, Wagner E, Nerlich AG (1997) Increased accumulation of the glycoxidation product N ε -(carboxymethyl)lysine in human tissues in diabetes and aging. J Clin Invest 99:457–468CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Stitt AW, He C, Friedman S et al. (1997) Elevated AGE-modified ApoB in sera of euglycemic, normolipidemic patients with atherosclerosis: relationship to tissue AGEs. Mol Med 3:617–627PubMedPubMedCentral Stitt AW, He C, Friedman S et al. (1997) Elevated AGE-modified ApoB in sera of euglycemic, normolipidemic patients with atherosclerosis: relationship to tissue AGEs. Mol Med 3:617–627PubMedPubMedCentral
3.
Zurück zum Zitat Miyata T, Wada Y, Cai Z et al. (1997) Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure. Kidney Int 51:1170–1181CrossRefPubMed Miyata T, Wada Y, Cai Z et al. (1997) Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure. Kidney Int 51:1170–1181CrossRefPubMed
4.
Zurück zum Zitat Smith MA, Taneda S, Richey PL et al. (1994) Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Proc Natl Acad Sci USA 91:5710–5714CrossRefPubMedPubMedCentral Smith MA, Taneda S, Richey PL et al. (1994) Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Proc Natl Acad Sci USA 91:5710–5714CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Monnier VM, Vishwanath V, Frank KE, Elmets CA, Dauchot P, Kohn RR (1986) Relation between complications of type 1 diabetes mellitus and collagen-linked fluorescence. N Eng J Med 314:403–408CrossRef Monnier VM, Vishwanath V, Frank KE, Elmets CA, Dauchot P, Kohn RR (1986) Relation between complications of type 1 diabetes mellitus and collagen-linked fluorescence. N Eng J Med 314:403–408CrossRef
6.
Zurück zum Zitat Baynes JW, Thorpe SR (1999) Role of oxidative stress in diabetic complications. A new perspective on an old Paradigm. Diabetes 48:1–9CrossRefPubMed Baynes JW, Thorpe SR (1999) Role of oxidative stress in diabetic complications. A new perspective on an old Paradigm. Diabetes 48:1–9CrossRefPubMed
7.
Zurück zum Zitat The DCCT research group (1993) The effect of intensive diabetes treatment on the development and progression of long-term complications in insulin-dependent diabetes: The Diabetes Control and Complications Trial. N Engl J Med 329:977–986CrossRef The DCCT research group (1993) The effect of intensive diabetes treatment on the development and progression of long-term complications in insulin-dependent diabetes: The Diabetes Control and Complications Trial. N Engl J Med 329:977–986CrossRef
8.
Zurück zum Zitat Monnier VM, Bautista O, Kenny D et al. (1999) Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes. Diabetes 48:870–880CrossRefPubMedPubMedCentral Monnier VM, Bautista O, Kenny D et al. (1999) Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes. Diabetes 48:870–880CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Monnier VM, Sell DR, Abdul-Karim FW, Emancipator SN (1988) Collagen browning and cross-linking are increased in chronic experimental hyperglycemia. Relevance to diabetes and ageing. Diabetes 37:867–872CrossRefPubMed Monnier VM, Sell DR, Abdul-Karim FW, Emancipator SN (1988) Collagen browning and cross-linking are increased in chronic experimental hyperglycemia. Relevance to diabetes and ageing. Diabetes 37:867–872CrossRefPubMed
10.
Zurück zum Zitat Nishikawa T, Edelstein D, Du XL et al. (2000) Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404:787–790CrossRefPubMed Nishikawa T, Edelstein D, Du XL et al. (2000) Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404:787–790CrossRefPubMed
11.
Zurück zum Zitat Thornalley PJ (1998) Cell activation by glycated proteins, AGE receptors, receptor recognition factors and functional classification of AGE. Cell Mol Biol 44:1013–1023PubMed Thornalley PJ (1998) Cell activation by glycated proteins, AGE receptors, receptor recognition factors and functional classification of AGE. Cell Mol Biol 44:1013–1023PubMed
12.
Zurück zum Zitat Beisswenger PJ, Makita Z, Curphey TJ et al. (1995) Formation of immunochemical advanced glycosylation end products precede and correlate with early manifestations of renal and retinal disease in diabetes. Diabetes 44:824–829CrossRefPubMed Beisswenger PJ, Makita Z, Curphey TJ et al. (1995) Formation of immunochemical advanced glycosylation end products precede and correlate with early manifestations of renal and retinal disease in diabetes. Diabetes 44:824–829CrossRefPubMed
13.
Zurück zum Zitat Makita Z, Radoff S, Rayfield EJ et al. (1991) Advanced glycosylation end products in patients with diabetic nephropathy. N Engl J Med 325:836–842CrossRefPubMed Makita Z, Radoff S, Rayfield EJ et al. (1991) Advanced glycosylation end products in patients with diabetic nephropathy. N Engl J Med 325:836–842CrossRefPubMed
14.
Zurück zum Zitat Hammes HP, Brownlee M, Lin J, Schleicher E, Bretzel RG (1999) Diabetic retinopathy risk correlates with intracellular concentrations of the glycoxidation product N-epsilon-(carboxymethyl) lysine independently of glycohaemoglobin concentrations. Diabetologia 42:603–607CrossRefPubMed Hammes HP, Brownlee M, Lin J, Schleicher E, Bretzel RG (1999) Diabetic retinopathy risk correlates with intracellular concentrations of the glycoxidation product N-epsilon-(carboxymethyl) lysine independently of glycohaemoglobin concentrations. Diabetologia 42:603–607CrossRefPubMed
15.
Zurück zum Zitat Kiuchi K, Nejima J, Takano T, Ohta M, Hashimoto H (2001) Increased serum concentrations of advanced glycation end products: a marker of coronary artery disease activity in type 2 diabetic patients. Heart 85:87–91CrossRefPubMedPubMedCentral Kiuchi K, Nejima J, Takano T, Ohta M, Hashimoto H (2001) Increased serum concentrations of advanced glycation end products: a marker of coronary artery disease activity in type 2 diabetic patients. Heart 85:87–91CrossRefPubMedPubMedCentral
16.
17.
Zurück zum Zitat Wolffenbuttel BH, Boulanger CM, Crijns FR et al. (1998) Breakers of advanced glycation end products restore large artery properties in experimental diabetes. Proc Natl Acad Sci USA 95:4630–4634CrossRefPubMedPubMedCentral Wolffenbuttel BH, Boulanger CM, Crijns FR et al. (1998) Breakers of advanced glycation end products restore large artery properties in experimental diabetes. Proc Natl Acad Sci USA 95:4630–4634CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Soulis-Liparota T, Cooper M, Papazoglou D, Clarke B, Jerums G (1991) Retardation by aminoguanidine of development of albuminuria, mesangial expansion, and tissue fluorescence in streptozotocin-induced diabetic rats. Diabetes 40:1328–1335CrossRefPubMed Soulis-Liparota T, Cooper M, Papazoglou D, Clarke B, Jerums G (1991) Retardation by aminoguanidine of development of albuminuria, mesangial expansion, and tissue fluorescence in streptozotocin-induced diabetic rats. Diabetes 40:1328–1335CrossRefPubMed
19.
Zurück zum Zitat Hricik DE, Wu YC, Schulak A, Friedlander MA (1996) Disparate changes in plasma and tissue pentosidine levels after kidney and kidney-pancreas transplantation. Clin Transplantation 10:568–573 Hricik DE, Wu YC, Schulak A, Friedlander MA (1996) Disparate changes in plasma and tissue pentosidine levels after kidney and kidney-pancreas transplantation. Clin Transplantation 10:568–573
20.
Zurück zum Zitat Dorrian CA, Cathcart S, Clausen J, Shapiro D, Dominiczak MH (1998) Factors in human serum interfere with the measurement of advanced glycation endproducts. Cell Mol Biol 44:1069–1079PubMed Dorrian CA, Cathcart S, Clausen J, Shapiro D, Dominiczak MH (1998) Factors in human serum interfere with the measurement of advanced glycation endproducts. Cell Mol Biol 44:1069–1079PubMed
21.
Zurück zum Zitat Jager J, Oomen PHN, Sluiter WJ, Reitsma WD, Smit AJ (1997) Improved reproducibility of the “Large-Window” method of assessing transcapillary and interstitial fluorescein diffusion in the skin in healthy subjects and in subjects with insulin-dependent diabetes mellitus. Int J Microcirc Clin Exp 17:150–158CrossRefPubMed Jager J, Oomen PHN, Sluiter WJ, Reitsma WD, Smit AJ (1997) Improved reproducibility of the “Large-Window” method of assessing transcapillary and interstitial fluorescein diffusion in the skin in healthy subjects and in subjects with insulin-dependent diabetes mellitus. Int J Microcirc Clin Exp 17:150–158CrossRefPubMed
22.
Zurück zum Zitat Sato E, Mori F, Igarashi S et al. (2001) Corneal advanced glycation end products increase in patients with proliferative diabetic retinopathy. Diabetes Care 24:479–482CrossRefPubMed Sato E, Mori F, Igarashi S et al. (2001) Corneal advanced glycation end products increase in patients with proliferative diabetic retinopathy. Diabetes Care 24:479–482CrossRefPubMed
23.
Zurück zum Zitat Abiko T, Abiko A, Ishiko S et al. (1999) Relationship between autofluorescence and advanced glycation end products in diabetic lenses. Exp Eye Res 68:361–366CrossRefPubMed Abiko T, Abiko A, Ishiko S et al. (1999) Relationship between autofluorescence and advanced glycation end products in diabetic lenses. Exp Eye Res 68:361–366CrossRefPubMed
24.
Zurück zum Zitat Ishino Y, Yokoi N, Yashara T et al. (2001) Investigation of corneal autofluorescence in diabetic patients. Jpn J Opthalmol 45:116CrossRef Ishino Y, Yokoi N, Yashara T et al. (2001) Investigation of corneal autofluorescence in diabetic patients. Jpn J Opthalmol 45:116CrossRef
25.
Zurück zum Zitat Van Schaik HJ, Alkemade C, Swart W, van Best JA (1999) Autofluorescence of the diabetic and healthy human cornea in vivo at different excitation wavelengths. Exp Eye Res 68:1–8CrossRef Van Schaik HJ, Alkemade C, Swart W, van Best JA (1999) Autofluorescence of the diabetic and healthy human cornea in vivo at different excitation wavelengths. Exp Eye Res 68:1–8CrossRef
26.
Zurück zum Zitat Coremans JMC, Ince C, Bruining HA, Puppels GJ (1997) (Semi-) quantitative analysis of reduced nicotinamide adenine dinucleotide fluorescence images of blood perfused rat heart. Biophys J 72:1849–1860CrossRefPubMedPubMedCentral Coremans JMC, Ince C, Bruining HA, Puppels GJ (1997) (Semi-) quantitative analysis of reduced nicotinamide adenine dinucleotide fluorescence images of blood perfused rat heart. Biophys J 72:1849–1860CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Na R, Stender IM, Henriksen M, Wulf HC (2001) Autofluorescence of human skin is age-related after correction for skin pigmentation and redness. J Invest Dermatol 116:536–540CrossRefPubMed Na R, Stender IM, Henriksen M, Wulf HC (2001) Autofluorescence of human skin is age-related after correction for skin pigmentation and redness. J Invest Dermatol 116:536–540CrossRefPubMed
28.
Zurück zum Zitat Dyer DG, Dunn JA, Thorpe SR et al. (1993) Accumulation of Maillard reaction products in skin collagen in diabetes and aging. J Clin Invest 91:2463–2469CrossRefPubMedPubMedCentral Dyer DG, Dunn JA, Thorpe SR et al. (1993) Accumulation of Maillard reaction products in skin collagen in diabetes and aging. J Clin Invest 91:2463–2469CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Ahmed MU, Brinkmann-Frye E, Degenhardt TP, Thorpe SR, Baynes JW (1997) N ε -(carboxymethyl)lysine, a product of chemical modification of protein by methylglyoxal, increases with age in human lens proteins. Biochem J 324:565–570CrossRefPubMedPubMedCentral Ahmed MU, Brinkmann-Frye E, Degenhardt TP, Thorpe SR, Baynes JW (1997) N ε -(carboxymethyl)lysine, a product of chemical modification of protein by methylglyoxal, increases with age in human lens proteins. Biochem J 324:565–570CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Maekawa T, Rathinasamy TK, Altman KI, Forbes WF (1970) Changes in collagen with age. 1. The extraction of acid soluble collagen from the skin of mice. Exp Gerontol 5:177–186CrossRefPubMed Maekawa T, Rathinasamy TK, Altman KI, Forbes WF (1970) Changes in collagen with age. 1. The extraction of acid soluble collagen from the skin of mice. Exp Gerontol 5:177–186CrossRefPubMed
31.
Zurück zum Zitat Wolffenbuttel BHR, Giordano D, Founds HW, Bucala R (1996) Long-term assessment of glucose control by haemoglobin-AGE measurement. Lancet 347:513–515CrossRefPubMed Wolffenbuttel BHR, Giordano D, Founds HW, Bucala R (1996) Long-term assessment of glucose control by haemoglobin-AGE measurement. Lancet 347:513–515CrossRefPubMed
32.
Zurück zum Zitat Nicoll ID, Stitt AW, Moore JE (1998) Increased levels of advanced glycation endproducts in the lenses and blood vessels of cigarette smokers. Mol Med 4:594–601 Nicoll ID, Stitt AW, Moore JE (1998) Increased levels of advanced glycation endproducts in the lenses and blood vessels of cigarette smokers. Mol Med 4:594–601
33.
Zurück zum Zitat McCance DR, Dyer DG, Dunn JA et al. (1993) Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus. J Clin Invest 91:2470–2478CrossRefPubMedPubMedCentral McCance DR, Dyer DG, Dunn JA et al. (1993) Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus. J Clin Invest 91:2470–2478CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Koschinsky T, He CJ, Mitsuhashi T et al. (1997) Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy. Proc Natl Acad Sci USA 94:6474–6479CrossRefPubMedPubMedCentral Koschinsky T, He CJ, Mitsuhashi T et al. (1997) Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy. Proc Natl Acad Sci USA 94:6474–6479CrossRefPubMedPubMedCentral
Metadaten
Titel
Simple non-invasive assessment of advanced glycation endproduct accumulation
verfasst von
R. Meerwaldt
R. Graaff
P. H. N. Oomen
T. P. Links
J. J. Jager
N. L. Alderson
S. R. Thorpe
J. W. Baynes
R. O. B. Gans
A. J. Smit
Publikationsdatum
01.07.2004
Verlag
Springer Berlin Heidelberg
Erschienen in
Diabetologia / Ausgabe 7/2004
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-004-1451-2

Weitere Artikel der Ausgabe 7/2004

Diabetologia 7/2004 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.